… Acute bronchitis is an acute respiratory infection with a normal chest radiograph that is …
Beta2 agonists have shown statistically significant enhancement of mucociliary clearance rates in …

… Combining an inhaled LAMA with an ICS, a long-acting beta2 agonists (LABA) or both
given once a day appears to be a likely strategy for new products for asthma as well as chronic …

Background The extent of short-acting Beta-2-agonist (β 2 -agonist) (SABA) use across Asian
countries is not well documented. As part of the SABA use IN Asthma (SABINA) III study, …

… Long-acting beta2-agonists (LABAs) should not be taken for 12 hours prior to spirometry.The
National Asthma Council recommends different withholding times (see Table 2).…

… short-acting beta2-agonists (SABA) or long-acting beta2-agonists (LABA), including inhalation
solutions); R03B (Other drugs for obstructive airway diseases, inhalants, such as inhaled …

… Long-acting beta2-agonists (LABAs) should not be taken for 12 hours prior to spirometry.The
National Asthma Council recommends different withholding times (see Table 2).…

… 29.42%; p= 0.043) diagnoses were lower for TIO+ OLO with 24% reduced risk of experiencing
pneumonia/acute bronchitis/bronchiolitis diagnosis (adjusted HR= 0.76; 95% CI: 0.60-0.97…

… Background: Authors define acute bronchitis as a self-limiting … of cough of patients with
uncomplicated acute bronchitis. … patients with uncomplicated acute bronchitis treated with …

… are frequent/severe exacerbations with a faster pulmonary decline.[4] Acute exacerbation of
COPD … [5] This review will focus on the management of acute exacerbation of COPD, recent …

… In asthma therapy long-acting beta2-agonists (LABA) enhance the function of corticosteroids
and improve asthma control [10]. A possible explanation of this efficacy is represented by a …